GI
VNDA icon

GAMMA Investing’s Vanda Pharmaceuticals VNDA Stock Holding History

GAMMA Investing’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77K Sell
290
-261
-47% -$1.71K ﹤0.01% 3753
2026
Q1 		$3.81K Buy
551
+368
+201% +$2.84K ﹤0.01% 3471
2025
Q4 		$1.61K Buy
183
+120
+190% +$660 ﹤0.01% 3668
2025
Q3 		$314 Hold
63
– – ﹤0.01% 3761
2025
Q2 		$297 Buy
+63
New +$275 ﹤0.01% 3698
2025
Q1 		– Sell
-32
Closed -$153 – 3886
2024
Q4 		$153 Sell
32
-166
-84% -$797 ﹤0.01% 3729
2024
Q3 		$929 Sell
198
-38
-16% -$204 ﹤0.01% 3277
2024
Q2 		$1.33K Buy
+236
New +$1.22K ﹤0.01% 2994

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GAMMA Investing's VNDA Position: Q2 2026 in Review

GAMMA Investing reduced its Vanda Pharmaceuticals (VNDA) stake by 47% in Q2 2026, selling an estimated $1.71K and leaving 290 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3753.

GAMMA Investing first reported a position in VNDA in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.81K in Q1 2026. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • GAMMA Investing held 290 shares of Vanda Pharmaceuticals worth $1.77K as of Q2 2026.
  • GAMMA Investing sold 261 Vanda Pharmaceuticals shares in Q2 2026, an estimated $1.71K.
  • Vanda Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3753 holding.
  • GAMMA Investing first reported a position in Vanda Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • GAMMA Investing's Vanda Pharmaceuticals position peaked at $3.81K in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.